Shortage of Weight-Loss Drug Ozempic Affects Diabetes Patients
A shortage of the weight-loss drug Ozempic, popular among diabetes patients, has left many unable to access it, leading to potential health risks. The surge in demand is driven by non-diabetic individuals using it for weight loss, causing supply issues. Diabetes UK calls for a ban on off-label prescribing of Ozempic during the shortage.